Podcast

Pharmacy Focus Episode 30: An Inside Look From a Clinical Trial Participant

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.


In this week’s episode, we will be discussing what it is like to be in a clinical trial and how it feels to be a patient who is cancer-free with Toni English. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com
Related Content
HPV Immunization, New Data | Image Credit: ©kitsawet | stock.adobe.com
November 20th 2024

Investigators Present New Data About HPV Vaccine, Supporting Its Use

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

radiology x-ray lung cancer - Image credit: utah51 | stock.adobe.com
November 18th 2024

CHMP Recommends Lazertinib With Amivantamab to Treat EGFR-Mutated Advanced NSCLC

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

FDA approval stamp -- Image credit: Olivier Le Moal | stock.adobe.com
Published: November 15th 2024 | Updated: November 15th 2024

FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia

Gillian McGovern, Assistant Editor
Chronic myeloid leukemia (CML) in accelerated phase with thrombocytosis.
November 15th 2024

FDA Grants New Nilotinib Formulation Approval to Treat Adults With Chronic Myeloid Leukemia

Luke Halpern, Assistant Editor